160 related articles for article (PubMed ID: 26621604)
41. Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: success, morbidity and survival.
Fanning J; Yacoub E; Hojat R
Gynecol Oncol; 2011 Oct; 123(1):47-9. PubMed ID: 21741079
[TBL] [Abstract][Full Text] [Related]
42. The impact of splenectomy and diaphragmatic surgery on perioperative morbidity and overall survival of ovarian cancer patients.
Skowyra A; Szubert S; Rajs T; Nowakowski B; Wicherek L
Ginekol Pol; 2023; 94(10):807-815. PubMed ID: 36929791
[TBL] [Abstract][Full Text] [Related]
43. Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection.
Hoffman MS; Tebes SJ; Sayer RA; Lockhart J
Am J Obstet Gynecol; 2007 Aug; 197(2):209.e1-4; discussion 209.e4-5. PubMed ID: 17689654
[TBL] [Abstract][Full Text] [Related]
44. Reconstruction of the diaphragm with autologous fascia lata during cytoreduction in patients with advanced ovarian cancer.
Kanao H; Tsumura S
J Gynecol Oncol; 2023 Jul; 34(4):e43. PubMed ID: 36807746
[TBL] [Abstract][Full Text] [Related]
45. Stapled diaphragm resection: A new approach to diaphragmatic cytoreductive surgery for advanced-stage ovarian cancer.
Huber D; Fournier I; Christodoulou M; Seidler S; Besse V; Mathey MP; Nef J; Hurni Y
Eur J Obstet Gynecol Reprod Biol; 2022 Dec; 279():88-93. PubMed ID: 36283249
[TBL] [Abstract][Full Text] [Related]
46. Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity.
Tozzi R; Ferrari F; Nieuwstad J; Campanile RG; Soleymani Majd H
J Gynecol Oncol; 2020 Mar; 31(2):e14. PubMed ID: 31912672
[TBL] [Abstract][Full Text] [Related]
47. En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report.
dos Santos LA; Modica I; Flores RM; D'Angelica M; Aghajanian C; Chi DS; Abu-Rustum NR
Gynecol Oncol; 2006 Sep; 102(3):596-8. PubMed ID: 16782176
[TBL] [Abstract][Full Text] [Related]
48. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
[TBL] [Abstract][Full Text] [Related]
49. [Classification and morbidity of debulking surgery for advanced ovarian cancer].
Vincens E; Lauratet B; Lefranc JP
Bull Cancer; 2010 Jan; 97(1):73-7. PubMed ID: 20080457
[TBL] [Abstract][Full Text] [Related]
50. [Strategies and techniques for resection of upper abdominal disease in patients with advanced ovarian cancer].
Terauchi F
Nihon Rinsho; 2012 Jun; 70 Suppl 4():576-80. PubMed ID: 23156313
[No Abstract] [Full Text] [Related]
51. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
[TBL] [Abstract][Full Text] [Related]
52. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
[TBL] [Abstract][Full Text] [Related]
53. Colon resection for ovarian cancer: intraoperative decisions.
Hoffman MS; Zervose E
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
[TBL] [Abstract][Full Text] [Related]
54. Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer.
Panuccio E; Leunen K; Van Nieuwenhuysen E; Neven P; Lambrechts S; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1521-4. PubMed ID: 27488213
[TBL] [Abstract][Full Text] [Related]
55. Assessment of intraoperative tube thoracostomy after diaphragmatic resection as part of debulking surgery for primary advanced-stage Müllerian cancer.
Kato K; Tate S; Nishikimi K; Shozu M
Gynecol Oncol; 2013 Oct; 131(1):32-5. PubMed ID: 23891788
[TBL] [Abstract][Full Text] [Related]
56. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
Chi DS; Franklin CC; Levine DA; Akselrod F; Sabbatini P; Jarnagin WR; DeMatteo R; Poynor EA; Abu-Rustum NR; Barakat RR
Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354
[TBL] [Abstract][Full Text] [Related]
57. Role of minimally invasive surgery in ovarian cancer.
Nezhat FR; Pejovic T; Finger TN; Khalil SS
J Minim Invasive Gynecol; 2013; 20(6):754-65. PubMed ID: 24183269
[TBL] [Abstract][Full Text] [Related]
58. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
59. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma.
Vergote I; Amant F; Van Gorp T
Int J Gynecol Cancer; 2009 Apr; 19(3):481. PubMed ID: 19407579
[No Abstract] [Full Text] [Related]
60. Ovarian cancer: patterns of surgical care across the United States.
Goff BA; Matthews BJ; Wynn M; Muntz HG; Lishner DM; Baldwin LM
Gynecol Oncol; 2006 Nov; 103(2):383-90. PubMed ID: 17005244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
